(NaturalNews) Radiation therapy for the treatment of brain tumors may lead to cognitive decline later in life, according to a study conducted by researchers from VU University Medical Centre in Amsterdam, Netherlands, and published in The Lancet Neu…
A newly approved ‘morning after’ pill may do a better job of preventing unwanted pregnancies than the widely used pill levonorgestrel, researchers say. The new treatment, called ulipristal acetate, can also be used up to five days after a woman has unprotected sex, compared with just three days for levonorgestrel. What do we know already? [...]
Matt Chandler doesn’t feel anything when the radiation penetrates his brain. It could start to burn later in treatment.
Singer Etta James is hospitalized for treatment of a serious infection, but her son said Friday he’s more concerned with her Alzheimer’s diagnosis.
PHILADELPHIA, Jan. 29 /PRNewswire/ — GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for a new combination regimen using TYKERB® (lapatinib) as a first-line, all-oral t…
Grammy-winning R&B singer Etta James has been hospitalized for about a week near her Southern California home for treatment of various ailments.
WASHINGTON (Reuters) – Employer-provided group health plans must offer the same level of coverage for mental illness and drug abuse treatment as for other ailments, according to federal regulations issued on Friday.
Data Demonstrating a 35% Overall Response Rate with a Median Progression-Free Survival of 12.6 Months in Patients with Relapsed or Relapsed/Refractory Waldenstrom’s Macroglobulinemia to be Published in the February 1, 2010 Issue of the Journal of Clini…
Data Demonstrating a 35% Overall Response Rate with a Median Progression-Free Survival of 12.6 Months in Patients with Relapsed or Relapsed/Refractory Waldenstrom’s Macroglobulinemia to be Published in the February 1, 2010 Issue of the Journal of Clini…
ZURICH (Reuters) – Swiss biotechnology group Basilea said it would resume recruitment of patients into a late-stage trial of an antifungal treatment in the first half of 2010 after a U.S. safety panel recommended the study’s continuation.